GAPDH over-expression may be attributed to compensate for the progressive decrease in muscle mitochondrial function due to FFA induced ROS and contribute to loss of glucose and lipid homeostasis and eventually obesity and T2D [112], [113]. The gene discussed is GAPDH; the disease is obesity due to melanocortin 4 receptor deficiency.